INSIGHTS ON CLINICAL TRIAL DESIGN

• Operationalizing Immuno-Oncology Studies

  Managing CRS and immune risks demands early detection, rapid response, and skilled teams. Strong infrastructure and clear protocols enable safer immunotherapy trials beyond academic centers.

• The Psychedelic Setback: What MDMA Rejection Taught Drug Developers

  Psychedelic compounds show real promise for PTSD, but proving it requires solving unblinding, bias, and safety gaps in trial design.

• A Mission To Expand Recruitment Territory

  Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.

• Together, We Are On A Mission: Enabling Treatments To Reach Patients

  This AI-powered digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.

• The Strategic Backbone Of Marketing Application Success

  3/12/2025

  Through proactive timeline management and strategic oversight, organizations can achieve their regulatory goals with confidence.

• Rethinking Patient Representation In Breast Cancer Trials For Better Outcomes

  5/22/2026

  Broad patient representation in breast cancer trials is critical, and inclusive trial design improves data relevance, accelerates enrollment, and supports global approval and access.

• SCOPE 2026 In The Rear-View Mirror

  2/18/2026

  Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.

• Hey There. We're Scout

  4/22/2026

  Learn how clear workflows, proactive support, and accessible technology help translate services into real participant retention.

• Is Your Clinical Research Site GCP-Ready?

  4/9/2025

  By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.